No Data
No Data
Xinghua Co., Ltd. (002109.SZ): Net loss of 149 million yuan in the first quarter
On April 25, Ge Longhui Co., Ltd. (002109.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 908 million yuan, up 35.28% year on year; net profit attributable to shareholders of listed companies - 149 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 139 million yuan; basic earnings per share - 0.1,166 yuan.
Express News | Xinghua Co., Ltd.: Expected net profit loss of 320 million yuan to 450 million yuan in 2023
A-share midday announcement: The subsidiary of Xinghua Co., Ltd. completed the maintenance plan and resumed single operation
Gelonghui, January 8 | In the afternoon, several listed companies issued announcements. The details are as follows: ① Xidian Pharmaceutical: The company recently received the “Notice of Acceptance” issued by the State Drug Administration for the registration and marketing of drugs produced domestically produced in the country for oral solution of protein and iron succinate. Protein iron succinate oral solution is used for absolute and relative iron deficiency anemia such as hidden or overt iron deficiency anemia due to insufficient iron intake or absorption disorder, acute or chronic blood loss, and infection, and anemia during pregnancy and breastfeeding. ② Chuanheng Co., Ltd.: The company plans to increase the capital of its wholly-owned subsidiary Chuanheng Ecology by 50 million yuan to meet the operating and construction capital requirements. Chuanheng Ecology is mainly responsible
Xinghua Co., Ltd.: Xinghua Chemical has completed all maintenance plans except for the Beitao air separation plant and has resumed single operation
Gelonghui, January 8 | Xinghua Co., Ltd. announced that Xinghua Chemical has completed all maintenance plans except for the Beitao air separation plant and will resume single operation on January 6, 2024. During the major maintenance period, the Xinghua Chemical Beitao air separation plant discovered that the distillation tower sieve plate was seriously damaged and needed to urgently purchase spare parts from the equipment manufacturer. Due to the long production and delivery cycle of spare parts for the device, it is expected that the double set will resume operation in February 2024.
Xinghua Co., Ltd. (002109.SZ) disclosed fixed increase results: UBS AG, CaiTong Fund and NORD Fund participated
On January 5, Gelonghui Co., Ltd. (002109.SZ) released a report on the issuance of shares to specific targets. It determined that the issuance price was 4.03 yuan/share, the number of shares issued was 223 million shares, and the total capital raised was about 90 million yuan. The specific placement results are as follows:
Xinghua Co., Ltd. (002109.SZ): Recently, the subsidiary Xinghua Chemical is in the final stage of routine annual maintenance, and production is expected to resume soon
Gelonghui, December 29丨Some investors asked Xinghua Co., Ltd. (002109.SZ) on the investor interactive platform, “There is information that Xinghua Group will relocate. Does it have any impact on listed companies? Will there be any impact on the planned increase projects?” The company replied that recently, the company's subsidiary Xinghua Chemical is in the final stages of routine annual maintenance, and production is expected to resume soon. Please refer to the company's announcement for the exact time. Regarding your concerns about the impact of Xinghua Group's relocation on the company, the company has not yet received any official documents from the government or competent authorities clarifying the relocation, but considering the company's continued development, we will also coordinate
No Data